Negative regulation of NOD1 mediated angiogenesis by PPARγ-regulated miR-125a

Journal Article · Sun Jan 01 04:00:00 EST 2017 · Biochemical and Biophysical Research Communications

DOI:https://doi.org/10.1016/J.BBRC.2016.11.032· OSTI ID:22696735

Kang, Hyesoo; Park, Youngsook; Lee, Aram; Seo, Hyemin; Kim, Min Jung; Choi, Jihea; Jo, Ha-neul; Jeong, Ha-neul; Cho, Jin Gu ^[1]; Chang, Woochul ^[2]; Lee, Myeong-Sok ^[1]; Jeon, Raok ^[3]; Kim, Jongmin ^[1]

---

1. Department of Life Systems, Sookmyung Women's University, Seoul, 04310 (Korea, Republic of)
2. Department of Biology Education, College of Education, Pusan National University, Busan, 46241 (Korea, Republic of)
3. Research Center for Cell Fate Control, College of Pharmacy, Sookmyung Women's University, Seoul, 04310 (Korea, Republic of)

Infection with pathogens activates the endothelial cell and its sustained activation may result in impaired endothelial function. Endothelial dysfunction contributes to the pathologic angiogenesis that is characteristic of infection-induced inflammatory pathway activation. Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is a protein receptor which recognizes bacterial molecules and stimulates an immune reaction in various cells; however, the underlying molecular mechanisms in the regulation of inflammation-triggered angiogenesis are not fully understood. Here we report that peroxisome proliferator-activated receptor gamma (PPARγ)-mediated miR-125a serves as an important regulator of NOD1 agonist-mediated angiogenesis in endothelial cells by directly targeting NOD1. Treatment of human umbilical vein endothelial cells with natural PPARγ ligand, 15-Deoxy-Delta12,14-prostaglandin J2, led to inhibition of NOD1 expression; contrarily, protein levels of NOD1 were significantly increased by PPARγ knockdown. We report that PPARγ regulation of NOD1 expression is a novel microRNA-mediated regulation in endothelial cells. MiR-125a expression was markedly decreased in human umbilical vein endothelial cells subjected to PPARγ knockdown while 15-Deoxy-Delta12,14-prostaglandin J2 treatment increased the level of miR-125a. In addition, NOD1 is closely regulated by miR-125a, which directly targets the 3′ untranslated region of NOD1. Moreover, both overexpression of miR-125a and PPARγ activation led to inhibition of NOD1 agonist-induced tube formation in endothelial cells. Finally, NOD1 agonist increased the formation of cranial and subintestinal vessel plexus in zebrafish, and this effect was abrogated by concurrent PPARγ activation. Overall, these findings identify a PPARγ-miR-125a-NOD1 signaling axis in endothelial cells that is critical in the regulation of inflammation-mediated angiogenesis. - Highlights: • Expression of NOD1 is regulated by PPARγ signaling in HUVECs. • PPARγ-regulated NOD1 expression is mediated at least in part by of miR-125a. • NOD1 is a novel target gene of miR-125. • miR-125a inhibits inflammation induced angiogenesis in HUVECs. • PPARγ activation inhibits inflammation mediated angiogenesis in vitro and in vivo.

• OSTI ID: 22696735
• Journal Information: Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 1 Vol. 482; ISSN 0006-291X; ISSN BBRCA9
• Country of Publication: United States
• Language: English

Related Subjects

60 APPLIED LIFE SCIENCES
ANGIOGENESIS
IMMUNE REACTIONS
INFLAMMATION
INHIBITION
REGULATIONS